DE ROSE, Virginia
 Distribuzione geografica
Continente #
NA - Nord America 2.845
EU - Europa 2.364
AS - Asia 1.205
SA - Sud America 59
OC - Oceania 53
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.556
Nazione #
US - Stati Uniti d'America 2.652
CN - Cina 697
IT - Italia 354
FR - Francia 295
IE - Irlanda 289
GB - Regno Unito 276
DE - Germania 264
UA - Ucraina 204
JP - Giappone 198
SE - Svezia 162
CA - Canada 155
FI - Finlandia 149
KR - Corea 148
DK - Danimarca 81
PL - Polonia 67
BE - Belgio 66
AU - Australia 53
ES - Italia 44
VN - Vietnam 39
TR - Turchia 38
IN - India 32
BR - Brasile 31
MX - Messico 31
CH - Svizzera 20
NL - Olanda 18
SN - Senegal 18
PT - Portogallo 14
GR - Grecia 13
RU - Federazione Russa 11
AT - Austria 10
TW - Taiwan 9
CL - Cile 8
CZ - Repubblica Ceca 8
HK - Hong Kong 8
SA - Arabia Saudita 8
IL - Israele 6
IR - Iran 6
PE - Perù 6
PR - Porto Rico 6
AR - Argentina 5
CO - Colombia 5
EC - Ecuador 4
MY - Malesia 4
ZA - Sudafrica 4
SG - Singapore 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
IQ - Iraq 2
LV - Lettonia 2
MA - Marocco 2
RO - Romania 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
LK - Sri Lanka 1
NG - Nigeria 1
RS - Serbia 1
TH - Thailandia 1
Totale 6.556
Città #
Beijing 365
Chandler 344
Ann Arbor 290
Dublin 283
Jacksonville 136
Villeurbanne 112
Hangzhou 111
Redwood City 105
Princeton 98
Medford 96
Houston 81
Fairfield 80
Wilmington 76
Dearborn 71
Ashburn 68
Milan 61
Torino 56
Nyköping 54
Seattle 54
Warsaw 50
Toronto 47
New York 39
Woodbridge 39
Verona 38
Brussels 37
Boston 32
Dong Ket 28
Fremont 24
Cambridge 22
Shanghai 20
Boardman 19
Pisa 19
Falls Church 18
Nantes 16
Norwalk 16
Hefei 15
Lachine 15
Nanchang 15
Turin 15
Rome 14
Guangzhou 13
Granada 12
Belfast 11
London 11
Madison 11
Montréal 11
Montreal 10
Paris 10
Pune 9
Cardiff 8
Duncan 8
Hebei 8
Nanjing 8
Vienna 8
Jinan 7
Manchester 7
Zhengzhou 7
Auburn Hills 6
Bornem 6
Istanbul 6
Kansas City 6
Munich 6
Newcastle upon Tyne 6
Ottawa 6
Poitiers 6
Santa Cruz 6
Tokyo 6
Washington 6
Belvedere Spinello 5
Birmingham 5
Bristol 5
Central District 5
Chongqing 5
Denver 5
Hamilton 5
Iowa City 5
Lima 5
Madrid 5
Melbourne 5
Mississauga 5
Nottingham 5
Porto Alegre 5
Riyadh 5
San Diego 5
Santiago 5
Sydney 5
Aguadilla 4
Austin 4
Catania 4
Chengdu 4
Cincinnati 4
Cleveland 4
Damme 4
Decatur 4
Frankfurt am Main 4
Gent 4
Hanoi 4
Hanover 4
Harbin 4
Lanester 4
Totale 3.450
Nome #
CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease 1.682
Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial 354
Genetic deletion and pharmacological inhibition of PI3K γ reduces neutrophilic airway inflammation and lung damage in mice with cystic fibrosis-like lung disease 307
Bradykinin- and lipopolysaccharide-induced bradykinin B(2) receptor expression, interleukin 8 release and "nitrosative stress" in bronchial epithelial cells BEAS-2B: Role for neutrophils. 274
Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD 173
The guinea pig as an animal model for asthma 126
Airway Epithelium Dysfunction in Cystic Fibrosis and COPD 113
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 96
Clinical guidelines and indications for bronchoalveolar lavage (BAL): chronic bronchitis and emphysema. 92
Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis 88
Clinical guidelines and indications for bronchoalveolar lavage (BAL): bronchial asthma. 86
[Usefulness of chest X-ray during cystic fibrosis exacerbation in adult patients] 82
Adhesion receptor expression on peripheral blood T lymphocyte subsets after specific inhalation challenge. 80
[Clinical and pharmacokinetic study of ciprofloxacin at the level of the respiratory system] 79
The clinical role of BAL in idiopathic pulmonary fibrosis. 74
[Study of aspecific bronchial reactivity in subjects with allergic diseases and in bronchial asthma patients] 74
[Efficacy and tolerability of imipenem/cilastatin in infections at various sites] 74
[Effect of glycopeptide antibiotics on human phagocyte activity] 72
Are asthma-like symptoms due to bronchial or extrathoracic airway dysfunction? 71
[Effect of clofoctol on various parameters of phagocyte function] 71
Dysfunctional inflammation in cystic fibrosis airways: From mechanisms to novel therapeutic approaches 71
Evaluation of the host defense system in asthmatic patients. 70
[Use of aztreonam in the treatment of respiratory infections] 68
Evaluation of systemic host defense mechanisms in chronic bronchitis. 68
Double-blind trial RU 41740 vs. placebo: immunological and clinical effects in a group of patients with chronic bronchitis. 67
Roxithromycin (RU 28965) in the treatment of respiratory tract infections. 66
IFN-gamma inhibits the proliferation of allergen-activated T lymphocytes from atopic, asthmatic patients by inducing Fas/FasL-mediated apoptosis 65
Cyclin D1 blockade as a limiting factor of the granulomatous response in tuberculosis. 65
Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis 65
Proteomic analysis of sputum from adults with cystic fibrosis and COPD:identification of potential biomakers for disease monitoring. 63
[In vitro and ex vivo effect of antimicrobial agents on the chemotaxis of human neutrophils] 60
Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. 59
Role of chest radiography in the diagnosis of allergic bronchopulmonary aspergillosis in adult patients with cystic fibrosis. 57
Circulating adhesion molecules in cystic fibrosis. 56
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients. 55
CD8-positivity is not associated with IL4 and IL5 gene expression in chronic bronchitis. 55
Mechanisms and markers of airway inflammation in cystic fibrosis 54
The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms. 54
In vivo study of xibornol on phagocyte functions. 54
The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. 54
Tumor necrosis factor-alpha in airway secretions from cystic fibrosis patients upregulate endothelial adhesion molecules and induce airway epithelial cell apoptosis: implications for cystic fibrosis lung disease 54
[Function of the defense system in patients with primary neoplasms of the lung. Preliminary results] 52
Patterns of response to allergen challenge. 52
Increased numbers of airway wall plasma cells in smokers with chronic bronchitis: co-localization and gene expression for interleukin 4 and 5. 51
Circulating adhesion molecules in patients with cystic fibrosis. 50
Malattie respiratorie croniche ostruttive 49
Imipenem in acute lung infections and bacterial re-exacerbations of chronic obstructive lung disease. 49
[Pharmacokinetics of cofosfolactamines in subjects with impaired kidney function] 48
Interstitial pneumopathy and low-dosage amiodarone. 46
Influence of ceftriaxone on natural defense systems. 45
Increased numbers of airway mast cells in chronic bronchitis: localization and gene expression for interleukin 4,5 and TNF-alpha. 45
Inflammatory cytokines in airways secretions from patients with cystic fibrosis upregulate endothelial adhesion molecules in vitro. 45
Intercellular adhesion molecule-1 is upregulated on peripheral blood T lymphocyte subsets in dual asthmatic responders. 45
Lung immunoglobulin A immunity dysregulation in cystic fibrosis. 44
Relationship between total inflammatory cell number and lung function in large and small airways. 42
Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis. 40
Variation of CD8+ T-lymphocytes around the bronchial internal perimeter in chronic bronchitis. 40
Penetration of roxithromycin in bronchial secretions. 40
STRATEGIES IN THE PHARMACOLOGIC PREVENTION OF LUNG EMPHYSEMA. 39
Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis 39
"In vitro" effect of non steroidal antiinflammatory agents on mononuclear phagocyte functions. 39
Metabolism of arachidonic acid in human alveolar macrophages from patients with sarcoidosis. 37
Substance P increases neutrophil adhesion to bronchial epithelial cells 37
Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells. 36
Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate 36
Familial elevation of serum angiotensin converting enzyme activity. 35
Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. 35
Variation in CD8+ T cell counts in the bronchial wall of subjects with chronic bronchitis. 35
Elevation of serum type III procollagen N-terminal peptide levels in thoracic sarcoidosis: a possible index for fibroblast activity. 32
La semeiotica dell’Apparato Respiratorio 32
Gene expression and immunolocalization of 15-lipoxygenase isozymes in the airway mucosa of smokers with chronic bronchitis 32
EPITHELIAL CELL ADHESION MOLECULES AND INFLAMMATORY CELL/EPITHELIAL CELL INTERACTIONS 31
Substance P increases neutrophil adhesion to bronchial epithelial cells. 31
IL-4 and IL-5 mRNA in the bronchial wall of smokers. 31
Inflammatory changes in large and small airways of patients with chronic obstructive pulmonary disease. 31
IFN-gamma inhibits the proliferation of allergen-activated T lymphocytes from atopic asthmatic patients by inducing FAS/FASL-mediated apoptosis. 31
Mantle radiotherapy increases airway responsiveness. 30
Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease 28
CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis 2
Totale 6.810
Categoria #
all - tutte 15.221
article - articoli 0
book - libri 0
conference - conferenze 2.118
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019114 0 0 0 0 0 0 0 0 7 12 76 19
2019/2020995 37 24 78 95 94 104 113 62 135 73 100 80
2020/20211.030 110 50 74 66 115 66 85 47 137 114 53 113
2021/20221.162 61 66 52 78 111 90 99 74 51 65 165 250
2022/20231.252 152 84 56 84 105 298 144 93 110 31 62 33
2023/2024419 78 82 42 55 41 75 13 24 9 0 0 0
Totale 6.810